IL207906A0 - Treatment for ocular-related disorders - Google Patents

Treatment for ocular-related disorders

Info

Publication number
IL207906A0
IL207906A0 IL207906A IL20790610A IL207906A0 IL 207906 A0 IL207906 A0 IL 207906A0 IL 207906 A IL207906 A IL 207906A IL 20790610 A IL20790610 A IL 20790610A IL 207906 A0 IL207906 A0 IL 207906A0
Authority
IL
Israel
Prior art keywords
ocular
treatment
related disorders
disorders
Prior art date
Application number
IL207906A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of IL207906A0 publication Critical patent/IL207906A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL207906A 2008-03-10 2010-08-31 Treatment for ocular-related disorders IL207906A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
PCT/US2009/036119 WO2009114373A1 (en) 2008-03-10 2009-03-05 Treatment for ocular-related disorders

Publications (1)

Publication Number Publication Date
IL207906A0 true IL207906A0 (en) 2010-12-30

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207906A IL207906A0 (en) 2008-03-10 2010-08-31 Treatment for ocular-related disorders

Country Status (22)

Country Link
EP (1) EP2285378A1 (pt)
JP (1) JP2011513488A (pt)
KR (1) KR20110009084A (pt)
CN (1) CN101965188A (pt)
AR (1) AR070975A1 (pt)
AU (1) AU2009223501A1 (pt)
BR (1) BRPI0909659A2 (pt)
CA (1) CA2717991A1 (pt)
CL (1) CL2009000551A1 (pt)
CO (1) CO6290691A2 (pt)
CR (1) CR11644A (pt)
DO (1) DOP2010000266A (pt)
IL (1) IL207906A0 (pt)
MA (1) MA32211B1 (pt)
MX (1) MX2010008308A (pt)
NI (1) NI201000131A (pt)
NZ (1) NZ587906A (pt)
RU (1) RU2010141560A (pt)
SV (1) SV2010003658A (pt)
TW (1) TW200950784A (pt)
WO (1) WO2009114373A1 (pt)
ZA (1) ZA201005337B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1990343B1 (en) * 1999-12-24 2012-04-04 Aventis Pharma Limited Azaindoles
JP2003523390A (ja) * 2000-02-25 2003-08-05 メルク エンド カムパニー インコーポレーテッド チロシンキナーゼ阻害薬
WO2007041358A2 (en) * 2005-09-30 2007-04-12 Miikana Therapeutics, Inc. Substituted pyrazole compounds
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
AU2009223501A1 (en) 2009-09-17
KR20110009084A (ko) 2011-01-27
NI201000131A (es) 2011-09-29
BRPI0909659A2 (pt) 2015-09-22
RU2010141560A (ru) 2012-04-20
ZA201005337B (en) 2011-04-28
JP2011513488A (ja) 2011-04-28
NZ587906A (en) 2011-12-22
SV2010003658A (es) 2011-01-31
DOP2010000266A (es) 2010-09-30
MX2010008308A (es) 2010-08-11
CN101965188A (zh) 2011-02-02
MA32211B1 (fr) 2011-04-01
TW200950784A (en) 2009-12-16
CO6290691A2 (es) 2011-06-20
CL2009000551A1 (es) 2009-08-21
CA2717991A1 (en) 2009-09-17
CR11644A (es) 2010-11-22
AR070975A1 (es) 2010-05-19
EP2285378A1 (en) 2011-02-23
WO2009114373A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
WO2010144865A9 (en) Methods for treating gastrointestinal disorders
IL212986A0 (en) Methods for treating eye disorders
GB2467710B (en) Methods for treating social disorders
ZA201203342B (en) Treatments for gastrointestinal disorders
GB0822011D0 (en) Treatment
IL253293B (en) Desferrioxamine complexes of metals for the treatment of diseases related to the immune system
ZA201002167B (en) Treatment regime for proliferative disorders
ZA201202346B (en) Therapeutic agent for mood disorders
GB0807850D0 (en) Treatment device
GB0805818D0 (en) Therapeutic agents
GB0811992D0 (en) Treatment
GB0702537D0 (en) Treatment for excessive adiposity
IL213287A0 (en) Treatment for glomerulonephritis
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
ZA201005337B (en) Treatment for ocular-related disorders
GB0802201D0 (en) Treatment system
GB0820972D0 (en) Treatment
PT2278962E (pt) Métodos para o tratamento de desordens dermatológicas
GB0805912D0 (en) Treatment
GB0823273D0 (en) Treatment system
GB0820379D0 (en) Treatment
GB0820534D0 (en) Treatment
GB0816892D0 (en) Treatment